American Journal of Respiratory Cell and Molecular Biology. Vol. 27, pp. 752-758, 2002
© 2002 American Thoracic Society DOI: 10.1165/rcmb.4857
Prostaglandin E2 Synthesis and Suppression of Fibroblast Proliferation by Alveolar Epithelial Cells Is Cyclooxygenase-2Dependent
Vibha Lama,
Bethany B. Moore,
Paul Christensen,
Galen B. Toews and
Marc Peters-Golden
Division of Pulmonary and Critical Care Medicine, University of Michigan Health System; and Department of Veterans Affairs Medical Center, Ann Arbor, Michigan
Address correspondence to: Marc Peters-Golden, M.D., 6301 MSRB III, 1150 W. Medical Center Drive, Ann Arbor, MI 48109-0642. E-mail: petersm{at}umich.edu
Alveolar epithelial cells (AECs) may influence neighboring fibroblasts by the elaboration of prostaglandin E2 (PGE2). This prostanoid can be synthesized via "constitutive" cyclooxygenase (COX)-1 and "inducible" COX-2 enzyme isoforms. We compared AECs isolated from wild-type (WT), COX-1 knockout (KO), and COX-2 KO mice to determine the contribution of COX isoforms to AEC PGE2 synthesis and capacity for suppression of fibroblast proliferation in co-cultures. WT AECs constitutively expressed both COX-1 and COX-2 isoforms by immunoblot analysis. COX-1 KO cells and WT cells comparably augmented PGE2 synthesis following incubation with lipopolysaccharide or interleukin-1, whereas COX-2 KO cells were unable to do so. Surprisingly, however, constitutive generation of PGE2 was also dramatically reduced only in COX-2 KO cells. When co-cultured with WT murine lung fibroblasts, AECs from WT and COX-1 KO animals suppressed serum-induced fibroblast proliferation, whereas COX-2-deficient AECs caused a modest enhancement in fibroblast proliferation. These results indicate that PGE2 synthetic capacity in AECs is predominantly COX-2dependent under both basal and stimulated conditions. They also demonstrate conclusively that AECs can modulate fibroblast function by the elaboration of suppressive prostanoids. These alterations in AEC phenotype likely contribute to the propensity for pulmonary fibrosis observed in COX-2deficient mice.
Abbreviations: alveolar epithelial cell, AEC cyclooxygenase, COX Dulbecco's modified Eagle's medium, DMEM interleukin-1, IL-1 knockout, KO lipopolysaccharide, LPS prostaglandin E2, PGE2 prostacyclin, PGI2 wild type, WT
This article has been cited by other articles:

|
 |

|
 |
 
Y. H. Lee, Y. J. Suzuki, A. J. Griffin, and R. M. Day
Hepatocyte growth factor regulates cyclooxygenase-2 expression via {beta}-catenin, Akt, and p42/p44 MAPK in human bronchial epithelial cells
Am J Physiol Lung Cell Mol Physiol,
April 1, 2008;
294(4):
L778 - L786.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. White, Q. Ding, B. B. Moore, M. Peters-Golden, L. B. Ware, M. A. Matthay, and M. A. Olman
Prostaglandin E2 Mediates IL-1 -Related Fibroblast Mitogenic Effects in Acute Lung Injury through Differential Utilization of Prostanoid Receptors
J. Immunol.,
January 1, 2008;
180(1):
637 - 646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Carrier, I. Brochu, A. J. de Brum-Fernandes, and P. D'Orleans-Juste
The Inducible Nitric-Oxide Synthase Modulates Endothelin-1-Dependent Release of Prostacyclin and Inhibition of Platelet Aggregation ex Vivo in the Mouse
J. Pharmacol. Exp. Ther.,
December 1, 2007;
323(3):
972 - 978.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Huang, S. H. Wettlaufer, C. Hogaboam, D. M. Aronoff, and M. Peters-Golden
Prostaglandin E2 inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling
Am J Physiol Lung Cell Mol Physiol,
February 1, 2007;
292(2):
L405 - L413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Meng, S. Ceryak, Z. Aratsu, L. Jones, L. Epstein, and B. Bouscarel
Biphasic regulation by bile acids of dermal fibroblast proliferation through regulation of cAMP production and COX-2 expression level
Am J Physiol Cell Physiol,
September 1, 2006;
291(3):
C546 - C554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. B. Moore, L. Murray, A. Das, C. A. Wilke, A. B. Herrygers, and G. B. Toews
The Role of CCL12 in the Recruitment of Fibrocytes and Lung Fibrosis
Am. J. Respir. Cell Mol. Biol.,
August 1, 2006;
35(2):
175 - 181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Soberman and P. Christmas
Revisiting prostacyclin: new directions in pulmonary fibrosis and inflammation
Am J Physiol Lung Cell Mol Physiol,
August 1, 2006;
291(2):
L142 - L143.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Molina-Molina, A Serrano-Mollar, O Bulbena, L Fernandez-Zabalegui, D Closa, A Marin-Arguedas, A Torrego, J Mullol, C Picado, and A Xaubet
Losartan attenuates bleomycin induced lung fibrosis by increasing prostaglandin E2 synthesis
Thorax,
July 1, 2006;
61(7):
604 - 610.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Y. Park and J. W. Christman
Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases
Am J Physiol Lung Cell Mol Physiol,
May 1, 2006;
290(5):
L797 - L805.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Prasse, D. V. Pechkovsky, G. B. Toews, W. Jungraithmayr, F. Kollert, T. Goldmann, E. Vollmer, J. Muller-Quernheim, and G. Zissel
A Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18
Am. J. Respir. Crit. Care Med.,
April 1, 2006;
173(7):
781 - 792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Portnoy, T. Pan, C. A. Dinarello, J. M. Shannon, J. Y. Westcott, L. Zhang, and R. J. Mason
Alveolar type II cells inhibit fibroblast proliferation: role of IL-1{alpha}
Am J Physiol Lung Cell Mol Physiol,
February 1, 2006;
290(2):
L307 - L316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Selman and A. Pardo
Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers.
Proceedings of the ATS,
January 1, 2006;
3(4):
364 - 372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. B. Moore, M. N. Ballinger, E. S. White, M. E. Green, A. B. Herrygers, C. A. Wilke, G. B. Toews, and M. Peters-Golden
Bleomycin-Induced E Prostanoid Receptor Changes Alter Fibroblast Responses to Prostaglandin E2
J. Immunol.,
May 1, 2005;
174(9):
5644 - 5649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. White, R. G. Atrasz, E. G. Dickie, D. M. Aronoff, V. Stambolic, T. W. Mak, B. B. Moore, and M. Peters-Golden
Prostaglandin E2 Inhibits Fibroblast Migration by E-Prostanoid 2 Receptor-Mediated Increase in PTEN Activity
Am. J. Respir. Cell Mol. Biol.,
February 1, 2005;
32(2):
135 - 141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Hodges, R. G. Jenkins, C. P.D. Wheeler-Jones, D. M. Copeman, S. E. Bottoms, G. J. Bellingan, C. B. Nanthakumar, G. J. Laurent, S. L. Hart, M. L. Foster, et al.
Severity of Lung Injury in Cyclooxygenase-2-Deficient Mice Is Dependent on Reduced Prostaglandin E2 Production
Am. J. Pathol.,
November 1, 2004;
165(5):
1663 - 1676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Peters-Golden
When Defenses against Fibroproliferation Fail: Spotlight on an Axis of Prophylaxis
Am. J. Respir. Crit. Care Med.,
November 15, 2003;
168(10):
1141 - 1142.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Charbeneau, P. J. Christensen, C. J. Chrisman, R. Paine III, G. B. Toews, M. Peters-Golden, and B. B. Moore
Impaired synthesis of prostaglandin E2 by lung fibroblasts and alveolar epithelial cells from GM-CSF-/- mice: implications for fibroproliferation
Am J Physiol Lung Cell Mol Physiol,
June 1, 2003;
284(6):
L1103 - L1111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. B. Moore, M. Peters-Golden, P. J. Christensen, V. Lama, W. A. Kuziel, R. Paine III, and G. B. Toews
Alveolar epithelial cell inhibition of fibroblast proliferation is regulated by MCP-1/CCR2 and mediated by PGE2
Am J Physiol Lung Cell Mol Physiol,
February 1, 2003;
284(2):
L342 - L349.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 American Thoracic Society.
|
|
|